Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan.
about
Functional and molecular surveillance of Helicobacter pylori antibiotic resistance in Kuala LumpurTreatment of Helicobacter pylori infection.Enhancement of amoxicillin resistance after unsuccessful Helicobacter pylori eradication.Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pyloriHelicobacter pylori resistance to rifabutin in the last 7 years.Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: a systematic review and meta-analysis.Rapid detection of point mutations conferring resistance to fluoroquinolone in gyrA of Helicobacter pylori by allele-specific PCREfficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies.Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations.Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Helicobacter pylori Infection in the Dominican Republic.Helicobacter pylori: present status and future prospects in Japan.Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori.Helicobacter pylori eradication therapy.Optimal therapy for Helicobacter pylori infections.Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing.MOLECULAR DETECTION OF CLARITHROMYCIN AND FLUOROQUINOLONES RESISTANCE IN HELICOBACTER PYLORI INFECTION, DIRECTLY APPLIED TO GASTRIC BIOPSIES, IN AN URBAN BRAZILIAN POPULATION.Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation.Duodenal ulcer promoting gene 1 (dupA1) is associated with A2147G clarithromycin-resistance mutation but not interleukin-8 secretion from gastric mucosa in Iraqi patients.Sitafloxacin activity against Helicobacter pylori isolates, including those with gyrA mutations.Quinolone resistance in Helicobacter pylori isolates in Germany.Antibiotic resistance and gyrA mutation affect the efficacy of 10-day sitafloxacin-metronidazole-esomeprazole therapy for Helicobacter pylori in penicillin allergic patients.Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation.Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.Dual therapy for third-line Helicobacter pylori eradication and urea breath test prediction.Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimens.Microarray-Based Detection and Clinical Evaluation for Resistance to Clarithromycin or Levofloxacin and the Genotype of CYP2C19 in 1083 PatientsTen-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trialResistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance
P2860
Q28540466-B2AFAC96-F8F5-43AC-9854-ED6EDB4D969EQ33372344-2F39CD5D-2588-490D-8DA5-9EDABDBBD084Q35005169-E2A7099A-259B-4D5D-BD16-147449038FDBQ35104855-5362E164-710F-4B67-9A34-EAB1999F0F8CQ35363984-26A876FE-9809-4176-B8A6-215D81B8F1D5Q35529537-968321CE-310C-42FE-8605-7CD47DCDD06DQ35690423-D0CA2211-CAE6-476A-A215-1FAEEF1222B1Q35806155-2134A4B1-F81C-4C6F-B9E2-0C564B5638A2Q36181286-32759E27-7C6A-46B5-B8E8-3E3E6798C7DFQ36209645-D5AFD5A3-0F1E-4599-BE91-1C5A07DDCCECQ36279412-B78D3936-6509-400C-8CC4-3A3841E6C4BCQ36745437-B6C9DADB-354F-475D-95B3-65FBCBD62DC3Q37410463-062F28C7-B73B-4EDE-B689-9F33B2A981A6Q37721423-A2F8099C-F7BB-4966-810D-76F5CF26F368Q37835707-2591142A-D3E4-43FF-AB19-70E23518601FQ38490776-D67802B1-FEE5-45CD-8D6F-4705338DF55CQ40382489-A6F5537F-7AAE-480E-A5DC-7A71CCC6D1FFQ40892650-6FE2CCCD-A3C8-4A7C-806E-D6DCF382D017Q41026435-637DA6F8-09F4-43C9-8B5C-9EA63785BA3EQ41828456-9B46C7BC-1643-4134-873F-90B1CD6C1B30Q42112320-1B9DC726-6B27-4827-BD80-81D0BD86173AQ42284208-18A011E3-274E-4E65-B249-8D352CFA282EQ43153504-63747174-46F2-444B-872D-DF91C85AB1D6Q43164668-3ACC32BD-1123-4A12-BB09-2175BA499E7AQ43193083-AA5CE1BA-4E5C-4CDF-9661-85AF3AEB319AQ54945494-26E321EF-F8B6-42E7-B6C5-F0A15CFCE888Q57114157-EAE006A5-53C6-4FE7-8D14-9AC5BEF2F8B0Q57224739-F0216C97-8F4F-4108-9807-6F092156B2BAQ57225645-7FC310B3-6187-4E29-8B66-F4B7015373F0
P2860
Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Gatifloxacin resistance and mu ...... r pylori eradication in Japan.
@ast
Gatifloxacin resistance and mu ...... r pylori eradication in Japan.
@en
Gatifloxacin resistance and mu ...... r pylori eradication in Japan.
@nl
type
label
Gatifloxacin resistance and mu ...... r pylori eradication in Japan.
@ast
Gatifloxacin resistance and mu ...... r pylori eradication in Japan.
@en
Gatifloxacin resistance and mu ...... r pylori eradication in Japan.
@nl
prefLabel
Gatifloxacin resistance and mu ...... r pylori eradication in Japan.
@ast
Gatifloxacin resistance and mu ...... r pylori eradication in Japan.
@en
Gatifloxacin resistance and mu ...... r pylori eradication in Japan.
@nl
P2093
P2860
P1476
Gatifloxacin resistance and mu ...... er pylori eradication in Japan
@en
P2093
Hidekazu Suzuki
Hiroe Muraoka
Intetsu Kobayashi
Kumiko Kurabayashi
Mikiji Mori
Tatsuhiro Masaoka
Toshifumi Hibi
Toshihiro Nishizawa
P2860
P304
P356
10.1128/AAC.50.4.1538-1540.2006
P407
P577
2006-04-01T00:00:00Z